Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

EVH US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

EVH US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Evolent Health, Inc. Class A(EVH US)

$4.90+0.132.73%Ext:$5.99+1.0922.34%(Market Closed · 01:00:02 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Evolent Health, Inc. Class A(EVH US)

$4.90+0.132.73%Ext:$5.99+1.0922.34%(Market Closed · 01:00:02 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

Financials & Metrics

FinancialsChartingShort InterestEmployees

Evolent Health, Inc. Class A — Company Profile

Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.

Sector
Communication Services
Industry
Media
Exchange
UN
CEO
Seth Barrie Blackley
Headquarters
Arlington, VA, US
IPO Date
Jun 5, 2015
Employees
4,200
Website
www.evolent.com

Key Metrics

Price
$3.47
Market Cap
$390.31M
Revenue (TTM)
$496.25M
Net Income (TTM)
$-26632000.00
EPS (TTM)
-0.24
P/E (TTM)
-0.79
P/B (TTM)
0.98
Dividend Yield
0.00%
ROE (TTM)
-6.72%
ROA (TTM)
-1.42%
Operating Margin
-2.04%
Beta

Evolent Health, Inc. Class A — Company Profile

Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.

Sector
Communication Services
Industry
Media
Exchange
UN
CEO
Seth Barrie Blackley
Headquarters
Arlington, VA, US
IPO Date
Jun 5, 2015
Employees
4,200
Website
www.evolent.com

Key Metrics

Price
$3.47
Market Cap
$390.31M
Revenue (TTM)
$496.25M
Net Income (TTM)
$-26632000.00
EPS (TTM)
-0.24
P/E (TTM)
-0.79
P/B (TTM)
0.98
Dividend Yield
0.00%
ROE (TTM)
-6.72%
ROA (TTM)
-1.42%
Operating Margin
-2.04%
Beta
0.69

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.

Website
www.evolent.com
Location
Arlington, VA, US
Phone571 389 6000
Employees4,200
CEOSeth Barrie Blackley
Sector
Communication Services
Industry
Media
IPO DateJun 5, 2015

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

SEC Filings(842)

Expand
  • SC 13G/AEvolent Health, Inc.13 Nov
  • 8-KResults of Operations and Financial Condition5 Nov
  • 10-QQ3ended 30 Sept 20265 Nov
  • SC 13G/AEvolent Health, Inc.8 Sep
  • Form 4McCarthy Daniel Joseph28 Aug
  • Form 144McCarthy Daniel Joseph26 Aug
  • 10-QQ2ended 30 Jun 20266 Aug
  • 8-KResults of Operations and Financial Condition6 Aug
  • SC 13GEvolent Health, Inc.17 Jul
  • Form 4Blackley Seth6 Jul
  • Form 4Weinberg Jonathan6 Jul
  • Form 4McCarthy Daniel Joseph6 Jul
  • Form 4Shams Aammaad6 Jul
  • S-8Registration statement (employee benefit plan)10 Jun
  • Form 4Ajayi Toyin8 Jun
  • Form 4Glass Russell Monroe8 Jun
  • Form 4GRUA PETER J8 Jun
  • Form 4GUERTIN SHAWN M8 Jun
  • Form 4Jelinek Richard M8 Jun
  • Form 4KECK KIM8 Jun

News

  • Financial Review: Evolent Health (EVH) and Its Competitors11 Nov
  • Evolent Health, Inc. (EVH) Q3 2026 Earnings Call Transcript7 Nov
  • What Evolent Health (EVH) Said on Its Q3 Earnings Call7 Nov
  • Evolent Health (EVH) Matches Q3 Earnings Estimates5 Nov
  • Compared to Estimates, Evolent Health (EVH) Q3 Earnings: A Look at Key Metrics5 Nov
  • Evolent Announces Third Quarter 2026 Results5 Nov
  • Analyzing CareCloud (NASDAQ:CCLD) & Evolent Health (NYSE:EVH)16 Oct
  • Evolent To Release Third Quarter 2026 Financial Results on Thursday, November 5, 20269 Oct
  • Evolent Health, Inc (NYSE:EVH) Receives Consensus Recommendation of “Moderate Buy” from Brokerages7 Oct
  • TransPerfect Selected by Evolent for Enterprise-Wide Telephonic Interpretation21 Sep

Mentions in Filings

  • Mr. Barbarosh has extensive public and private company board experience. He has served as a member of the Board of Directors of <strong>Evolent Health, Inc.</strong> (NYSE: EVH) since 2020, where he currently serves as chair of the Strategy Committee and as a member of the Compensation Committee, and as a member of the Board of Directors of Sabra Health Care REIT, Inc. (NASDAQ: SBRA) since 2010, where he currently serves as chair of the Audit Committee and as a m …
    Braemar Hotels & Resorts Inc.Evolent Health, Inc. Class A·DEFA14A - Definitive additional materials·Q4 26·10 Nov
  • Mr. Barbarosh has extensive public and private company board experience. He has served as a member of the Board of Directors of <strong>Evolent Health, Inc.</strong> (NYSE: EVH) since 2020, where he currently serves as chair of the Strategy Committee and as a member of the Compensation Committee, and as a member of the Board of Directors of Sabra Health Care REIT, Inc. (NASDAQ: SBRA) since 2010, where he currently serves as chair of the Audit Committee and as a m …
    Braemar Hotels & Resorts Inc.Evolent Health, Inc. Class A·8-K - Entry into a Material Definitive Agreement·Q4 26·10 Nov
  • … and direct contracting models. In April 2025, the Company announced it had entered the state of Arizona in partnership with a multi-specialty practice. In December 2025, the Company acquired an ACO business from <strong>Evolent Health, Inc.</strong>, adding over 120,000 Attributed Lives through the MSSP and various commercial and Medicare Advantage programs. In May 2026, the Company announced it had entered the state of New Jersey in partnership with Neurolog …
    Privia Health Group, Inc.Evolent Health, Inc. Class A·10-Q - Quarterly report Q3·Q3 26·5 Nov
  • … ctors of Sabra Health Care REIT, Inc. (NASDAQ: SBRA) since 2010, where he currently serves as chair of the Audit Committee and as a member of the Compensation Committee, and as a member of the Board of Directors of <strong>Evolent Health, Inc.</strong> (NYSE: EVH) since 2020, where he currently serves as chair of the Strategy Committee and as a member of the Compensation Committee. Mr. Barbarosh previously served as Vice Chairman of NextGen Healthcare, Inc. (NASD …
    Braemar Hotels & Resorts Inc.Evolent Health, Inc. Class A·DEFA14A - Definitive additional materials·Q4 26·26 Oct
  • … ctor of CommonWealth Partners, an $8 billion real estate investment firm, and has served on the board of Sabra Health Care REIT since 2010, where he chairs the Audit Committee. He also chairs the Strategy Committee at <strong>Evolent Health</strong> and previously served as Vice Chairman of NextGen Healthcare and Chairman of Lifecore Biomedical. He holds a BA from the University of California, Santa Barbara and a JD from the University of the Pacific McGeorge Sch …
    Braemar Hotels & Resorts Inc.Evolent Health, Inc. Class A·EX-99.1 - DEFA14A - EXHIBIT 99.1·Q4 26·26 Oct
  • … ctor of CommonWealth Partners, an $8 billion real estate investment firm, and has served on the board of Sabra Health Care REIT since 2010, where he chairs the Audit Committee. He also chairs the Strategy Committee at <strong>Evolent Health</strong> and previously served as Vice Chairman of NextGen Healthcare and Chairman of Lifecore Biomedical. He holds a BA from the University of California, Santa Barbara and a JD from the University of the Pacific McGeorge Sch …
    Braemar Hotels & Resorts Inc.Evolent Health, Inc. Class A·EX-99.1 - 8-K - Regulation FD Disclosure·Q4 26·26 Oct

Key Stats

Trading

Px/Chg 1D$3.47 / +0.29%
Avg Volume2.93M
Beta0.69
Mkt Cap390.31M
FD Mkt Cap517.41M

Float

Shrs Out/Float112.48M / 107.68M
Short Float0.15%
Days to Cover5.90
Stock Repurchased$0.00

Current Valuation

EV1.21B
EV/EBITDA-4.00
EV/Sales0.64
P/B0.98
P/S0.21
FCF Yield-1.89%
ROE-6.72%
ROA-1.42%
Current Ratio1.32

Estimates

P/E-0.79
Est P/E0.00
Est EPS-0.05
Est PEG0.00

Valuation

Metric5Yr AvgMay '23May '24May '25May '26Oct '26
PRICE-BASED RATIOS
Price / Earnings-46.87-172.10-26.53-20.06-1.02-14.66
Price / Sales1.232.441.530.480.930.79
Price / Book Value1.983.842.811.231.050.98
Price / Free Cash Flow-56.73-66.0826.35-201.7410.66-52.82
ENTERPRISE VALUE METRICS
Enterprise Value2,273.63,586.13,451.31,845.71,275.31,209.7
Enterprise Value / Sales2.062.651.760.722.722.44
Enterprise Value / EBITDA9.9581.98-139.2521.75-3.4888.74
Enterprise Value / EBIT-57.66-77.11-23.29-48.17-3.10-136.63

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue19.9%908.01,352.01,963.92,554.71,876.2
Gross Income3.2%250.4316.6460.5367.4284.0
EBITDA—55.743.7-24.884.9-361.3
EBIT223.1%-4.4-46.5-148.2-38.3-477.2
Net Income94.2%-37.6-19.2-113.0-61.6-534.5
EPS (Diluted)93.7%-0.36-0.20-1.28-0.81-5.07
BALANCE SHEET
Cash & ST Inv-13.1%266.3188.2192.8163.5151.9
Total Assets7.6%1,419.51,817.32,680.32,544.41,899.2
Total Liabilities19.6%725.8957.91,612.61,543.21,484.0
Total Shareholder Equity-12%693.6859.41,067.71,001.3415.2
CASH FLOW
Net Operating Cash Flow6.2%38.7-11.6142.618.838.8
Cap Ex8.1%-25.0-38.4-28.7-24.9-34.1
Free Cash Flow-23.3%13.8-49.9113.8-6.14.8

Enterprise Value Bridge

Millions USD13 Nov '26
Price (As of 13 Nov '26)4.79
Basic Shares112.48
Market Cap538.2
Diluted Shares113.07
Fully Diluted Shares Outstanding113.07
Fully Diluted Market Cap541.0
+Consolidated Debt973.1
−In-the-Money Convertible Debt—
+Capital Leases3.6
+Operating Leases—
−Cash & Equivalents-148.3
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value1,363.0

Segment data

Revenue

by Products and services

  • Reportable Segment100%

Revenue

by Geography

  • Services Segment100%

Related companies

Cgi Inc

GIB US

Gartner Inc

IT US

Booz Allen Hamilton Holding Corp

BAH US

Fti Consulting, Inc

FCN US

Exponent Inc

EXPO US

Huron Consulting Group Inc.

HURN US

Astrana Health, Inc.

ASTH US

ICF International, Inc.

ICFI US

Montrose Environmental Group, Inc.

MEG US

Rmr Group Inc.

RMR US

Hackett Group, Inc.

HCKT US

Public Policy Holding Company, Inc.

PPHC US

0.69

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.

Website
www.evolent.com
Location
Arlington, VA, US
Phone571 389 6000
Employees4,200
CEOSeth Barrie Blackley
Sector
Communication Services
Industry
Media
IPO DateJun 5, 2015

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

SEC Filings(842)

Expand
  • SC 13G/AEvolent Health, Inc.13 Nov
  • 8-KResults of Operations and Financial Condition5 Nov
  • 10-QQ3ended 30 Sept 20265 Nov
  • SC 13G/AEvolent Health, Inc.8 Sep
  • Form 4McCarthy Daniel Joseph28 Aug
  • Form 144McCarthy Daniel Joseph26 Aug
  • 10-QQ2ended 30 Jun 20266 Aug
  • 8-KResults of Operations and Financial Condition6 Aug
  • SC 13GEvolent Health, Inc.17 Jul
  • Form 4Blackley Seth6 Jul
  • Form 4Weinberg Jonathan6 Jul
  • Form 4McCarthy Daniel Joseph6 Jul
  • Form 4Shams Aammaad6 Jul
  • S-8Registration statement (employee benefit plan)10 Jun
  • Form 4Ajayi Toyin8 Jun
  • Form 4Glass Russell Monroe8 Jun
  • Form 4GRUA PETER J8 Jun
  • Form 4GUERTIN SHAWN M8 Jun
  • Form 4Jelinek Richard M8 Jun
  • Form 4KECK KIM8 Jun

News

  • Financial Review: Evolent Health (EVH) and Its Competitors11 Nov
  • Evolent Health, Inc. (EVH) Q3 2026 Earnings Call Transcript7 Nov
  • What Evolent Health (EVH) Said on Its Q3 Earnings Call7 Nov
  • Evolent Health (EVH) Matches Q3 Earnings Estimates5 Nov
  • Compared to Estimates, Evolent Health (EVH) Q3 Earnings: A Look at Key Metrics5 Nov
  • Evolent Announces Third Quarter 2026 Results5 Nov
  • Analyzing CareCloud (NASDAQ:CCLD) & Evolent Health (NYSE:EVH)16 Oct
  • Evolent To Release Third Quarter 2026 Financial Results on Thursday, November 5, 20269 Oct
  • Evolent Health, Inc (NYSE:EVH) Receives Consensus Recommendation of “Moderate Buy” from Brokerages7 Oct
  • TransPerfect Selected by Evolent for Enterprise-Wide Telephonic Interpretation21 Sep

Mentions in Filings

  • Mr. Barbarosh has extensive public and private company board experience. He has served as a member of the Board of Directors of <strong>Evolent Health, Inc.</strong> (NYSE: EVH) since 2020, where he currently serves as chair of the Strategy Committee and as a member of the Compensation Committee, and as a member of the Board of Directors of Sabra Health Care REIT, Inc. (NASDAQ: SBRA) since 2010, where he currently serves as chair of the Audit Committee and as a m …
    Braemar Hotels & Resorts Inc.Evolent Health, Inc. Class A·DEFA14A - Definitive additional materials·Q4 26·10 Nov
  • Mr. Barbarosh has extensive public and private company board experience. He has served as a member of the Board of Directors of <strong>Evolent Health, Inc.</strong> (NYSE: EVH) since 2020, where he currently serves as chair of the Strategy Committee and as a member of the Compensation Committee, and as a member of the Board of Directors of Sabra Health Care REIT, Inc. (NASDAQ: SBRA) since 2010, where he currently serves as chair of the Audit Committee and as a m …
    Braemar Hotels & Resorts Inc.Evolent Health, Inc. Class A·8-K - Entry into a Material Definitive Agreement·Q4 26·10 Nov
  • … and direct contracting models. In April 2025, the Company announced it had entered the state of Arizona in partnership with a multi-specialty practice. In December 2025, the Company acquired an ACO business from <strong>Evolent Health, Inc.</strong>, adding over 120,000 Attributed Lives through the MSSP and various commercial and Medicare Advantage programs. In May 2026, the Company announced it had entered the state of New Jersey in partnership with Neurolog …
    Privia Health Group, Inc.Evolent Health, Inc. Class A·10-Q - Quarterly report Q3·Q3 26·5 Nov
  • … ctors of Sabra Health Care REIT, Inc. (NASDAQ: SBRA) since 2010, where he currently serves as chair of the Audit Committee and as a member of the Compensation Committee, and as a member of the Board of Directors of <strong>Evolent Health, Inc.</strong> (NYSE: EVH) since 2020, where he currently serves as chair of the Strategy Committee and as a member of the Compensation Committee. Mr. Barbarosh previously served as Vice Chairman of NextGen Healthcare, Inc. (NASD …
    Braemar Hotels & Resorts Inc.Evolent Health, Inc. Class A·DEFA14A - Definitive additional materials·Q4 26·26 Oct
  • … ctor of CommonWealth Partners, an $8 billion real estate investment firm, and has served on the board of Sabra Health Care REIT since 2010, where he chairs the Audit Committee. He also chairs the Strategy Committee at <strong>Evolent Health</strong> and previously served as Vice Chairman of NextGen Healthcare and Chairman of Lifecore Biomedical. He holds a BA from the University of California, Santa Barbara and a JD from the University of the Pacific McGeorge Sch …
    Braemar Hotels & Resorts Inc.Evolent Health, Inc. Class A·EX-99.1 - DEFA14A - EXHIBIT 99.1·Q4 26·26 Oct
  • … ctor of CommonWealth Partners, an $8 billion real estate investment firm, and has served on the board of Sabra Health Care REIT since 2010, where he chairs the Audit Committee. He also chairs the Strategy Committee at <strong>Evolent Health</strong> and previously served as Vice Chairman of NextGen Healthcare and Chairman of Lifecore Biomedical. He holds a BA from the University of California, Santa Barbara and a JD from the University of the Pacific McGeorge Sch …
    Braemar Hotels & Resorts Inc.Evolent Health, Inc. Class A·EX-99.1 - 8-K - Regulation FD Disclosure·Q4 26·26 Oct

Key Stats

Trading

Px/Chg 1D$3.47 / +0.29%
Avg Volume2.93M
Beta0.69
Mkt Cap390.31M
FD Mkt Cap517.41M

Float

Shrs Out/Float112.48M / 107.68M
Short Float0.15%
Days to Cover5.90
Stock Repurchased$0.00

Current Valuation

EV1.21B
EV/EBITDA-4.00
EV/Sales0.64
P/B0.98
P/S0.21
FCF Yield-1.89%
ROE-6.72%
ROA-1.42%
Current Ratio1.32

Estimates

P/E-0.79
Est P/E0.00
Est EPS-0.05
Est PEG0.00

Valuation

Metric5Yr AvgMay '23May '24May '25May '26Oct '26
PRICE-BASED RATIOS
Price / Earnings-46.87-172.10-26.53-20.06-1.02-14.66
Price / Sales1.232.441.530.480.930.79
Price / Book Value1.983.842.811.231.050.98
Price / Free Cash Flow-56.73-66.0826.35-201.7410.66-52.82
ENTERPRISE VALUE METRICS
Enterprise Value2,273.63,586.13,451.31,845.71,275.31,209.7
Enterprise Value / Sales2.062.651.760.722.722.44
Enterprise Value / EBITDA9.9581.98-139.2521.75-3.4888.74
Enterprise Value / EBIT-57.66-77.11-23.29-48.17-3.10-136.63

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue19.9%908.01,352.01,963.92,554.71,876.2
Gross Income3.2%250.4316.6460.5367.4284.0
EBITDA—55.743.7-24.884.9-361.3
EBIT223.1%-4.4-46.5-148.2-38.3-477.2
Net Income94.2%-37.6-19.2-113.0-61.6-534.5
EPS (Diluted)93.7%-0.36-0.20-1.28-0.81-5.07
BALANCE SHEET
Cash & ST Inv-13.1%266.3188.2192.8163.5151.9
Total Assets7.6%1,419.51,817.32,680.32,544.41,899.2
Total Liabilities19.6%725.8957.91,612.61,543.21,484.0
Total Shareholder Equity-12%693.6859.41,067.71,001.3415.2
CASH FLOW
Net Operating Cash Flow6.2%38.7-11.6142.618.838.8
Cap Ex8.1%-25.0-38.4-28.7-24.9-34.1
Free Cash Flow-23.3%13.8-49.9113.8-6.14.8

Enterprise Value Bridge

Millions USD13 Nov '26
Price (As of 13 Nov '26)4.79
Basic Shares112.48
Market Cap538.2
Diluted Shares113.07
Fully Diluted Shares Outstanding113.07
Fully Diluted Market Cap541.0
+Consolidated Debt973.1
−In-the-Money Convertible Debt—
+Capital Leases3.6
+Operating Leases—
−Cash & Equivalents-148.3
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value1,363.0

Segment data

Revenue

by Products and services

  • Reportable Segment100%

Revenue

by Geography

  • Services Segment100%

Related companies

Cgi Inc

GIB US

Gartner Inc

IT US

Booz Allen Hamilton Holding Corp

BAH US

Fti Consulting, Inc

FCN US

Exponent Inc

EXPO US

Huron Consulting Group Inc.

HURN US

Astrana Health, Inc.

ASTH US

ICF International, Inc.

ICFI US

Montrose Environmental Group, Inc.

MEG US

Rmr Group Inc.

RMR US

Hackett Group, Inc.

HCKT US

Public Policy Holding Company, Inc.

PPHC US